Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: Toward new means to control the spread of resistance?

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 9, 2012, Pages 4973-4975

  Nguyen, Thu Thuy ^a,b   Chachaty, Elisabeth ^c   Huy, Clarisse ^d   Cambier, Carole ^e   De Gunzburg, Jean ^d   Mentré, France ^a,b,g   Andremont, Antoine ^a,f,g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Da Volterra   (France)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f Emergence de la Résistance Bactérienne in Vivo ^*  (France)

^g BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PLACEBO; QUINOLONE;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CORRELATIONAL STUDY; ENTEROBACTERIACEAE; FECES ANALYSIS; INFECTION RESISTANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PIGLET; PRIORITY JOURNAL; SKIN BLOOD VESSEL;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BACTERIAL LOAD; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; FECES; PLACEBOS; SWINE;

EID: 84865443265     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06402-11     Document Type: Article

References (12)

1. Baquero F, Coque TM, de la Cruz F. 2011. Ecology and evolution as targets: the need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob. Agents Chemother. 55:3649-3660.
2. Donskey C. 2004. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39:219-226. (Pubitemid 38971493)
3. Fantin B, et al. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390-398.
4. Khoder L, Tsapis N, Domergue-Dupont V, Gueutin C, Fattal E. 2010. Removal of residual colonic ciprofloxacin in the rat by activated charcoal entrapped within zinc-pectinate beads. Eur. J. Pharm. Sci. 41:281-288.
5. Kitsis MD. 2009. Measurement of antibiotics in human body fluids. In Courvalin P, Leclercq R, Rice L (ed), Antibiogram. ESKA and ASM Press, Washington, DC.
6. Lee SS, Kim Y, Chung DR. 2011. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J. Infect. Dis. 62:159-164.
7. Mølbak K, et al. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N. Engl. J. Med. 341:1420-1425. (Pubitemid 29513457)
8. Moreno E, et al. 2008. Relationship between Escherichia coli strains causing acute cystitis in women and the fecal E. coli population of the host. J. Clin. Microbiol. 46:2529-2534.
9. Pecquet S, Ravoire S, Andremont A. 1990. Faecal excretion of ciprofloxacin after a single oral dose and its effect on faecal bacteria in healthy volunteers. J. Antimicrob. Chemother. 26:125-129. (Pubitemid 20263705)
10. Perrin-Guyomard A, Poul J-M, Corpet D, Sanders P, Haydée Fernández A, Bartholomew M. 2005. Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model. Regul. Toxicol. Pharmacol. 42:151-160. (Pubitemid 40826560)
11. Tancrède C, Andremont A. 1985. Bacterial translocation and Gram-negative bacteremia in patients with hematological malignancies. J. Infect. Dis. 152:99-103. (Pubitemid 15038840)
12. Wiuff C, Lykkesfeldt J, Svendsen O, Aarestrup FM. 2003. The effects of oral and intramuscular administration and dose escalation of enrofloxacin on the selection of quinolone resistance among Salmonella and coliforms in pigs. Res. Vet. Sci. 75:185-193. (Pubitemid 37192997)